Eurand N.V.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Eurand N.V. - overview

Established

1984

Location

Amsterdam, -, Netherlands

Primary Industry

Pharmaceuticals

About

Headquartered in Netherlands, Eurand is an oral drug-delivery company with integrated research, development and production facilities in Europe and North America. The company focuses on the development of pharmaceuticals and biopharmaceuticals to treat a range of illnesses.


Current Investors

TPG, Adare Pharma Solutions

Primary Industry

Pharmaceuticals

Sub Industries

Biopharmaceuticals, Pharmaceutical Research & Development

Website

www.eurand.com

Verticals

Manufacturing

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Eurand N.V. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-on, Trade SaleCompletedEurand N.V.-
Private Placement/Follow onCompletedEurand N.V.-
IPOCompletedEurand N.V.-
BuyoutCompletedEurand N.V.-

Displaying 1 - 4 of 4

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.